EXHIBIT 4 SERIES B CONVERTIBLE PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT THIS SERIES B CONVERTIBLE PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT (this "Agreement") is made and entered into effective as of March 4, 2004, by and among...Convertible Preferred Stock and Warrant Purchase Agreement • May 17th, 2004 • Trans Industries Inc • Miscellaneous manufacturing industries • Ohio
Contract Type FiledMay 17th, 2004 Company Industry Jurisdiction
EXHIBIT 10.12 CONVERTIBLE PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT Between SkyLynx Communications, Inc. and AMRO International, S.A. CONVERTIBLE PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT dated as of January 18, 1999 (the "Agreement"),...Convertible Preferred Stock and Warrant Purchase Agreement • July 26th, 1999 • Skylynx Communications Inc • Services-computer integrated systems design • New York
Contract Type FiledJuly 26th, 1999 Company Industry Jurisdiction
Exhibit 10.6 SERIES A CONVERTIBLE PREFERRED STOCK AND WARRANT PURCHASE AGREEMENTConvertible Preferred Stock and Warrant Purchase Agreement • March 29th, 1996 • Medical Sterilization Inc • Services-misc health & allied services, nec • New York
Contract Type FiledMarch 29th, 1996 Company Industry Jurisdiction
ARTICLE I DEFINITIONSConvertible Preferred Stock and Warrant Purchase Agreement • December 30th, 1996 • American International Group Inc • Fire, marine & casualty insurance • New York
Contract Type FiledDecember 30th, 1996 Company Industry Jurisdiction
IDERA PHARMACEUTICALS, INC. CONVERTIBLE PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT November 4, 2011Convertible Preferred Stock and Warrant Purchase Agreement • November 10th, 2011 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledNovember 10th, 2011 Company Industry JurisdictionThis Convertible Preferred Stock and Warrant Purchase Agreement (this “AGREEMENT”) is entered into as of the date set forth above by and among Idera Pharmaceuticals, Inc., a Delaware corporation (the “COMPANY”), and the undersigned purchasers (each a “PURCHASER” and collectively, the “PURCHASERS”) set forth on the Schedule of Purchasers attached hereto as Exhibit A (the “SCHEDULE OF PURCHASERS”). The parties hereby agree as follows:
IDERA PHARMACEUTICALS, INC. CONVERTIBLE PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT November 9, 2012Convertible Preferred Stock and Warrant Purchase Agreement • November 14th, 2012 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledNovember 14th, 2012 Company Industry JurisdictionThis Convertible Preferred Stock and Warrant Purchase Agreement (this “AGREEMENT”) is entered into as of the date set forth above by and among Idera Pharmaceuticals, Inc., a Delaware corporation (the “COMPANY”), and the undersigned purchasers (each a “PURCHASER” and collectively, the “PURCHASERS”) set forth on the Schedule of Purchasers attached hereto as Exhibit A (the “SCHEDULE OF PURCHASERS”). The parties hereby agree as follows:
ADEX MEDIA, INC. SERIES A CONVERTIBLE PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT June ___, 2009Convertible Preferred Stock and Warrant Purchase Agreement • August 14th, 2009 • Adex Media, Inc. • Services-business services, nec • Delaware
Contract Type FiledAugust 14th, 2009 Company Industry JurisdictionThis Series A Convertible Preferred Stock and Warrant Purchase Agreement (“Agreement”) is made as of June __, 2009, by and among Adex Media, Inc., a Delaware corporation (the “Company”), with its principal executive office at 883 N. Shoreline Boulevard, Suite A-200, Mountain View, CA 94043, and the purchasers listed on the Schedule of Purchasers attached as Schedule I hereto (each a “Purchaser” and collectively the “Purchasers”).
IDERA PHARMACEUTICALS, INC. AMENDMENT NO. 1 TO CONVERTIBLE PREFERRED STOCK AND WARRANT PURCHASE AGREEMENTConvertible Preferred Stock and Warrant Purchase Agreement • November 14th, 2012 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledNovember 14th, 2012 Company Industry JurisdictionThis Amendment No. 1 to Convertible Preferred Stock and Warrant Purchase Agreement (this “Agreement”) is made as of November 9, 2012, by and between Idera Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Pillar Pharmaceuticals I, L.P. (the “Purchaser”).